Author： Huang Yi-Shin
Publisher： Future Medicine
ISSN： 1741-0541
Source： Personalized Medicine, Vol.7, Iss.1, 2010-01, pp. : 5-8
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Biomarkers for drug-induced liver injury
Therapy, Vol. 7, Iss. 4, 2010-07 ,pp. :
Access to resources
Recommend
Genetic and Molecular Factors in Drug-Induced Liver Injury: A Review
Current Drug Safety, Vol. 2, Iss. 2, 2007-01 ,pp. :
Severe drug‐induced liver injury related to therapy with dimethyl fumarate
HEPATOLOGY, Vol. 64, Iss. 4, 2016-10 ,pp. :
Managing the Risk of Drug‐Induced Liver Injury
CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 94, Iss. 6, 2013-12 ,pp. :
Histopathological challenges in suspected drug‐induced liver injury
LIVER INTERNATIONAL (ELECTRONIC), Vol. 38, Iss. 2, 2018-02 ,pp. :